ALOT · As filed with the SEC
AstroNova income statement, by fiscal year
The statement as AstroNova presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Income (Loss) · USD
| USD | FY2026 Year ended Jan 31, 2026 | FY2025 Year ended Jan 31, 2025 | FY2024 Year ended Jan 31, 2024 | FY2023 Year ended Jan 31, 2023 | FY2022 Year ended Jan 31, 2022 | FY2021 Year ended Jan 31, 2021 | FY2020 Year ended Jan 31, 2020 | FY2019 Year ended Jan 31, 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 150,515,000 | 151,283,000 | 148,086,000 | 142,527,000 | 117,480,000 | 116,033,000 | 133,446,000 | 136,657,000 |
| Cost of Revenue | 102,881,000 | 98,534,000 | 96,465,000 | 94,371,000 | 73,741,000 | 74,673,000 | 84,688,000 | 82,658,000 |
| Gross Profit | 47,634,000 | 52,749,000 | 51,621,000 | 48,156,000 | 43,739,000 | 41,360,000 | 48,758,000 | 53,999,000 |
| Costs and Expenses: | ||||||||
| Selling and Marketing | 22,963,000 | 25,560,000 | 24,428,000 | 24,456,000 | 23,177,000 | 23,301,000 | 26,884,000 | 26,343,000 |
| Research and Development | 6,788,000 | 6,610,000 | 6,906,000 | 6,822,000 | 6,753,000 | 6,206,000 | 8,084,000 | 7,813,000 |
| General and Administrative | 16,380,000 | 15,816,000 | 11,491,000 | 11,435,000 | 9,553,000 | 9,420,000 | 11,357,000 | 11,123,000 |
| Goodwill Impairment | 297,000 | 13,403,000 | — | — | — | — | — | — |
| Operating Expenses | 46,428,000 | 61,389,000 | 42,825,000 | 42,713,000 | 39,483,000 | 38,927,000 | 46,325,000 | 45,279,000 |
| Operating Income (Loss) | 1,206,000 | (8,640,000) | 8,796,000 | 5,443,000 | 4,256,000 | 2,433,000 | 2,433,000 | 8,720,000 |
| Other Income (Expense): | ||||||||
| Interest Income (Expense), net | — | — | — | — | — | (955,000) | — | — |
| Gain (Loss) on Foreign Currency Transactions | — | — | — | — | — | (590,000) | — | — |
| Interest Expense | — | — | (2,697,000) | (1,678,000) | (677,000) | — | (826,000) | (876,000) |
| Investment Income | — | — | — | — | — | — | 143,000 | 145,000 |
| Interest Expense | (3,503,000) | (3,210,000) | — | — | — | — | — | — |
| Gain (Loss) on Foreign Currency Transactions | (146,000) | 335,000 | (83,000) | (474,000) | (288,000) | — | — | — |
| Gain on Extinguishment of Debt – PPP Loan | — | — | 0 | 0 | 4,466,000 | — | — | — |
| Loss on Disposal of Assets | — | — | 0 | 0 | (696,000) | — | — | — |
| Other, net | (93,000) | (772,000) | 57,000 | 119,000 | (27,000) | 111,000 | (380,000) | (681,000) |
| Total Other Income (Expense) | (3,742,000) | (3,647,000) | (2,723,000) | (2,033,000) | 2,778,000 | (254,000) | (1,063,000) | (1,412,000) |
| Income (Loss) before Income Taxes | (2,536,000) | (12,287,000) | 6,073,000 | 3,410,000 | 7,034,000 | 2,179,000 | 1,370,000 | 7,308,000 |
| Income Tax Expense (Benefit) | (160,000) | 2,202,000 | 1,379,000 | 749,000 | 605,000 | 895,000 | (389,000) | 1,578,000 |
| Net Income (Loss) | (2,376,000) | (14,489,000) | 4,694,000 | 2,661,000 | 6,429,000 | 1,284,000 | 1,759,000 | 5,730,000 |
| Net Income (Loss) Per Common Share-Basic | (0.31) | (1.93) | 0.63 | 0.36 | 0.89 | 0.18 | 0.25 | 0.83 |
| Net Income (Loss) Per Common Share-Diluted | (0.31) | (1.93) | 0.63 | 0.36 | 0.88 | 0.18 | 0.24 | 0.81 |
| Weighted Average Number of Common Shares Outstanding—Basic | 7,614,000 | 7,509,000 | 7,415,000 | 7,307,000 | 7,207,000 | 7,104,000 | 7,024,000 | 6,881,000 |
| Dilutive Effect of Common Stock Equivalents | — | 0 | 81,000 | 67,000 | 132,000 | 62,000 | 214,000 | 203,000 |
| Weighted Average Number of Common Shares Outstanding—Diluted | 7,614,000 | 7,509,000 | 7,496,000 | 7,374,000 | 7,339,000 | 7,166,000 | 7,238,000 | 7,084,000 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.